News

News

A community group are sat in a close circle for a discussion

Doctors in low- and middle-income countries say ‘yes’ to long-acting treatments for Hepatitis C

17 April 2024

LONGEVITY consortium group photo

Major funding extension to advance revolutionary long-acting therapeutic technologies

03 April 2024

Every member who attended the LONGEVITY consortium are stood together smiling at the camera

Liverpool host LONGEVITY consortium

07 August 2023

A stack of papers being held together with colourful clips

Researchers from the Centre of Excellence for Long-acting Therapeutics featured prominently in leading scientific journal for clinical infectious diseases

02 December 2022

A scientist is working in their lab

Developing a single-injection cure for hepatitis C virus for low- and middle-income countries

29 July 2022

A community group are sat in a close circle for a discussion

Community engagement – shaping the long-acting technologies pipeline

29 July 2022

Sign up to our newsletter

 

Any personal information you provide will be held in accordance with The EU General Data Protection Regulation (GDPR). For more information please see our Privacy notice

Our funding

The LONGEVITY Project is funded by Unitaid

The Unitaid logo is the organisation name written above the words

The project also involves critical partners and collaborators in the Clinton Health Access Initiative, Johns Hopkins University, Medicines Patent Pool, Tandem Nano Ltd., Treatment Action Group and the University of Nebraska Medical Center

The Clinton Health Access Initiative logo is the name with a ring of stars flying from itJohns Hopkins University logo is the Institution name under its crestThe Medicines Patent Pool logo is the organisation name to the right of three interconnecting circlesThe Tandem Nano Ltd logo is the organisation name to the right of a stylised letter T graphicThe Treatment Action Group logo is the Acronym The UNMC logo is the initialisation with the words